Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tumor
Biotech
Merck KGaA tacks on Abbisko’s joint tumor med for $70M upfront
Merck's mission of relying more on dealmaking was capped off with Monday's $70 million Abbisko announcement.
Max Bayer
Dec 4, 2023 10:26am
Deciphera's tumor-tackling oral med achieves 40% response rate
Oct 30, 2023 11:00am
Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials
Jun 7, 2022 8:30am
Novartis tags Molecular Partners for $580M radioligand deal
Dec 14, 2021 10:34am
Pfizer adds to $65M Parthenon war chest for tumor barrier battle
Nov 3, 2021 12:00pm
NIH blood test spots cancer in those with genetic predisposition
Sep 1, 2021 10:30am